Ekso Bionics Holdings Inc (NAS:EKSO)
$ 0.61 0.005 (0.83%) Market Cap: 13.31 Mil Enterprise Value: 11.08 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 60/100

Q4 2019 Ekso Bionics Holdings Inc Earnings Call Transcript

Feb 27, 2020 / 09:30PM GMT
Release Date Price: $5.06 (-9.48%)
Operator

Greetings and welcome to the Ekso Bionics Fourth Quarter 2019 Financial Results Conference Call. (Operator Instructions). As a reminder, this conference is being recorded.

It's now my pleasure to introduce your host, Matt Steinberg. Please go ahead, sir.

Matt Steinberg
Lazar Partners Ltd. - Associate Director

Thank you, operator, and thank you all for participating in today's call. Joining me from Ekso Bionics are Jack Peurach, President and Chief Executive Officer; John Glenn, Chief Financial Officer; and Bill Shaw, Chief Commercial Officer.

Earlier today, Ekso Bionics released financial results for the quarter and full year ended December 31, 2019. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities law, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot